Quality of life and comorbidity score as prognostic determinants in non-small-cell lung cancer patients.
about
Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008.A comprehensive review of nongenetic prognostic and predictive factors influencing the heterogeneity of outcomes in advanced non-small-cell lung cancerDiagnosis and management of hyponatremia in cancer patientsRole of tolvaptan in the management of hyponatremia in patients with lung and other cancers: current data and future perspectivesReporting performance of prognostic models in cancer: a review.The distress thermometer as a predictor for survival in stage III lung cancer patients treated with chemotherapy.Pretreatment quality of life is an independent prognostic factor for overall survival in patients with advanced stage non-small cell lung cancer.Health-related quality of life in advanced non-small cell lung cancer: correlates and comparisons to normative data.Relationship between deficits in overall quality of life and non-small-cell lung cancer survivalPrognostic value of quality of life score in disease-free survivors of surgically-treated lung cancerInfluence of Comorbidities on the Efficacy of Radiotherapy with or without Chemotherapy in Elderly Stage III Non-small Cell Lung Cancer PatientsComorbidities and survival in a large cohort of patients with newly diagnosed myelodysplastic syndromes.Quality of life supersedes the classic prognosticators for long-term survival in locally advanced non-small-cell lung cancer: an analysis of RTOG 9801.Prognostic value of serum cytokeratin 19 fragments (Cyfra 21-1) in patients with non-small cell lung cancer.Simplified comorbidity score for elderly patients undergoing thoracoscopic surgery for lung cancer.History, molecular features, and clinical importance of conventional serum biomarkers in lung cancer.Hyponatremia as an independent prognostic factor in patients with terminal cancer.Hyponatremia of non-small cell lung cancer: Indian experience.Tolvaptan use in cancer patients with hyponatremia due to the syndrome of inappropriate antidiuretic hormone: a post hoc analysis of the SALT-1 and SALT-2 trialsSurvival and prognostic factors after moderately hypofractionated palliative thoracic radiotherapy for non-small cell lung cancer.A decade of community-based outcomes of patients treated with curative radiotherapy with or without chemotherapy for non-small cell lung cancer.Comorbidity as prognostic variable in MDS: comparative evaluation of the HCT-CI and CCI in a core dataset of 419 patients of the Austrian MDS Study Group.Fractionated palliative thoracic radiotherapy in non-small cell lung cancer - futile or worth-while?Efficacy of second-line treatment and importance of comorbidity scores and clinical parameters affecting prognosis in elderly patients with non-small cell lung cancer without epidermal growth factor receptor mutations.Systematic short-term pulmonary rehabilitation before lung cancer lobectomy: a randomized trial.Can we predict the development of serious adverse events (SAEs) and early treatment termination in elderly non-small cell lung cancer (NSCLC) patients receiving platinum-based chemotherapy?Causes of death in long-term survivors of non-small cell lung cancer: A regional Surveillance, Epidemiology, and End Results study.Socio-demographic, Clinical, and Genetic Determinants of Quality of Life in Lung Cancer Patients
P2860
Q22241762-77C889E7-1D4E-4BA7-94D6-782C70D0A73DQ26865662-231F46A9-5610-40C8-86F8-029A57D13EDEQ27027817-CCA45238-E2C2-45B9-9A85-6213119C76C0Q28072768-F4A85DE6-4949-40C1-813D-BC89062C0111Q33547696-275A0298-40D7-4869-A8A9-DE2BED236BD3Q33829634-A403A345-0A48-4F44-B901-8C2D52D1B15DQ34196497-4B242B95-25F4-4543-B7C7-620B0EFF8450Q34240483-B2BF205D-9DA2-4B2C-A477-9F282456B904Q36058286-F9BF2177-12B9-4AC4-93D5-B7D66DE15449Q36083164-CCEB3188-07A4-4F83-BE52-DEFDBB0C4C1EQ36536988-A9D40735-F74A-4CF2-A8FF-B3A0EDC78CD3Q37359690-CC43123A-869B-48DF-A5EA-4C9F1E19134EQ37474276-4B049FA7-820B-413C-A0A5-F0E7F660081FQ37744346-2B18206D-B41F-41CE-A6E5-0C442E16F408Q38815074-EFCD858A-1A47-4A55-A3E0-67780BC9141FQ38947077-19A84E21-B27B-4DAF-90EA-C23D08EE1878Q39092737-4D0F0AE9-F91A-424E-84D2-78A3158D606DQ42145227-49740512-8F7D-42ED-ADFA-A86C440B4E03Q42292313-67C12463-58C7-4C4C-92CF-054A48FC738DQ43858217-8A10849C-37C5-4174-BF8F-EDDF2BA27AC0Q44794265-5816CA79-D140-44D6-9920-AE6B425F0A2EQ45928400-CE8E711A-A8E7-40AB-ABC6-7F24E49D0385Q47179342-98C7BCBE-1AE9-483E-A19B-2C42691A85DDQ47824998-2FAAF226-02FF-41F6-8C8B-117D5E1D8A4FQ47887745-C4AA02A2-302F-4645-8C55-97653A4BD587Q50240602-D851A6E7-01BE-4290-B604-61E5F394DB71Q52718118-E7E751FB-57FC-4D42-8634-BE3D20706219Q56243510-912ABD81-6490-4230-8AD3-B1163E553F27
P2860
Quality of life and comorbidity score as prognostic determinants in non-small-cell lung cancer patients.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Quality of life and comorbidit ...... all-cell lung cancer patients.
@en
Quality of life and comorbidit ...... all-cell lung cancer patients.
@nl
type
label
Quality of life and comorbidit ...... all-cell lung cancer patients.
@en
Quality of life and comorbidit ...... all-cell lung cancer patients.
@nl
prefLabel
Quality of life and comorbidit ...... all-cell lung cancer patients.
@en
Quality of life and comorbidit ...... all-cell lung cancer patients.
@nl
P2093
P2860
P356
P1433
P1476
Quality of life and comorbidit ...... all-cell lung cancer patients.
@en
P2093
D Bertrand
J-P Daurès
M-C Bozonnat
OncoLR health network
P2860
P304
P356
10.1093/ANNONC/MDN064
P577
2008-03-19T00:00:00Z